Sava raises €16.6M Series A round
31 July 2025· London, United Kingdom· health, digital_health, biosensors, wearables, b2c, software_hardware
The funding will be used to accelerate regulatory approval and commercialisation of its next-generation wearable, as well as scale its growing team, grow its team, increase manufacturing capacity, and fast-track the regulatory process for its first product, a pain-free, affordable, and accurate Continuous Glucose Monitor (CGM).
Investors
LeadBalderton Capital
Also participating
Italian Founders FundNorrsken VCJamJar InvestmentsExceptional VenturesAthletico VenturesPentland VenturesTrue
About Sava
Stage
Series A
Headquarters
London, United Kingdom
Founded
2019
Team Size
51–200
Sectors
healthdigital_healthbiosensorswearablesb2csoftware_hardware